A research showed that miR-378a-3p was related with favorable prognosis in ovarian cancer, which could suppress cell proliferation, promote cell apoptosis, and enhance the sensitivity to cisplatin by sponging MAPK1 and GRB2 (36). This evidence concerns the gene GRB2 and ovarian cancer.